The present invention is directed to novel 2,3-dihydro-1H-isoindol-1-imine derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the thrombin PAR-1 receptor antagonists.
                            本发明涉及新型2,3-二氢-
1H-异吲哚-1-
亚胺衍
生物、含有它们的制药组合物以及它们在治疗由凝血酶PAR-1受体拮抗剂调节的疾病和病症中的用途。